CEO of EGeen International speaks at the European Entrepreneurship and Innovation Thought Leaders Seminar at Stanford University
Mountain View, CA. – March 30, 2009. Kalev Kask, the CEO of EGeen International, will be discussing opportunities for the Company’s innovative business strategies of advancing the drug development of biotech and pharmaceutical clients via expeditious and high quality yet cost-effective clinical trials. Stanford University's European Entrepreneurship and Innovation Thought Leaders Seminar is a weekly speaker series that presents industry leaders from Europe's hitech startup, venture finance, corporate and university research and technology commercialization communities to share their insights and experiences with aspiring and veteran entrepreneurs from Silicon Valley. The European Entrepreneurship and Innovation Thought Leaders Seminar (EEITL) is a weekly lecture series on entrepreneurship and technology innovation as practiced in Europe — and by Europeans in Silicon Valley — co-sponsored by the Department of Mechanical Engineering and the University’s European Government Partners. The seminar is free and Open to the Public, and is affiliated with the Stanford Technology Ventures Program. Dr. Kask is schedule to speak on April 6, 2009 at 5 pm. For further information, please see http://www.europeanentrepreneursatstanford.com/. Kalev Kask, PhD |